Deva Holding A.s. · BIST:DEVA

Deva Holding A.s — Investor Presentation (October 2014)

10 slides from Deva Holding A.s's investor presentation, October 2014

1. Slide 1: your

   your reliable ) urce & fer S Ou macau yy

2. Slide 2: Content

   Content  Manufacturing  Development  Sales & Marketing  Business Models 2

3. Slide 3: Manufacturing Capabilities

   Manufacturing Capabilities Cerkezkoy Headquarters Kartepe (Tekirdag) (Istanbul) (Izmit) 3

4. Slide 4: DEVA Cerkezkoy Site I

   DEVA Cerkezkoy Site I Facilities landed on 52.000 m² area Total covered area 32.000 m² 4

5. Slide 5: DEVA Cerkezkoy Site II

   DEVA Cerkezkoy Site II Facilities landed on 68.000 m² area Total covered area 19.000 m² 5

6. Slide 6: DEVA Kartepe Site

   DEVA Kartepe Site Facilities landed on 32.000 m² area Total covered area 17.000 m² 6

7. Slide 7: Manufacturing Capabilities

   Manufacturing Capabilities ABILITY TO PRODUCE DIFFERENT PHARMACEUTICAL FORMS  Tablets & Capsules  Injectables (ampoules & vials)  BFS LVP & SVP  Sterile Pomads  Gels & Ointments  Suspensions  Suppositories  Syrups and Drops  DPI & MDI Inhaler 7

8. Slide 8: Product Development Capabilities

   Product Development Capabilities R&D Center  170 Scientists  Finished dosage form & API research and development  345 products in Turkish Market  Developments for US and EU Markets  R&D Award* 8 * DEVA was selected as the best R&D company in pharma industry by the Turkish Ministry of Science, T

9. Slide 9: Business Models

   Business Models Out-license & Supply API export Contract manufacturing Distribution DEVA branded sales Co-development in Europe 9

10. Slide 10: Thank You For Your Interest

    Thank You For Your Interest www.deva.com.tr/en 10

Deva Holding A.S. — Investor Presentation (October 2014) on 6ix